NASDAQ · OGI
Healthcare · Drug Manufacturers - Specialty & Generic
$1.05
Down-$0.02 (-1.87%)
Updated Sep 12, 2026, 6:07 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
OGI closed at $1.05 after 20 trading sessions, down 14.63% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.07 | $1.07 | $1.04 | $1.05 | 463.88K |
| Sep 10, 2026 | $1.09 | $1.11 | $1.065 | $1.07 | 372.82K |
| Sep 9, 2026 | $1.10 | $1.115 | $1.08 | $1.10 | 495.77K |
| Sep 8, 2026 | $1.15 | $1.15 | $1.10 | $1.12 | 1.22M |
| Sep 4, 2026 | $1.15 | $1.16 | $1.13 | $1.155 | 443.33K |
| Sep 3, 2026 | $1.19 | $1.21 | $1.13 | $1.17 | 843.57K |
| Sep 2, 2026 | $1.18 | $1.21 | $1.17 | $1.19 | 298.3K |
| Sep 1, 2026 | $1.20 | $1.21 | $1.17 | $1.18 | 140.26K |
| Aug 31, 2026 | $1.21 | $1.22 | $1.18 | $1.21 | 271.99K |
| Aug 28, 2026 | $1.21 | $1.23 | $1.195 | $1.215 | 668.69K |
| Aug 27, 2026 | $1.24 | $1.25 | $1.20 | $1.23 | 914.09K |
| Aug 26, 2026 | $1.26 | $1.275 | $1.25 | $1.26 | 345.42K |
| Aug 25, 2026 | $1.25 | $1.29 | $1.25 | $1.27 | 197.7K |
| Aug 24, 2026 | $1.24 | $1.27 | $1.20 | $1.26 | 631.6K |
| Aug 21, 2026 | $1.21 | $1.265 | $1.20 | $1.25 | 522.49K |
| Aug 20, 2026 | $1.23 | $1.24 | $1.18 | $1.20 | 826.01K |
| Aug 19, 2026 | $1.21 | $1.25 | $1.21 | $1.24 | 547.18K |
| Aug 18, 2026 | $1.22 | $1.24 | $1.20 | $1.21 | 533.61K |
| Aug 17, 2026 | $1.22 | $1.26 | $1.20 | $1.225 | 785.76K |
| Aug 14, 2026 | $1.25 | $1.28 | $1.20 | $1.23 | 1.01M |
The latest Smart Investors Daily articles mentioning OGI.
OGI research
Company profile and research snapshot.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 12, 2026 | ATB CAPITAL MARKETS | Outperform | — |
| May 11, 2026 | ALLIANCE GLOBAL PARTNERS | Buy | — |
| May 11, 2026 | HAYWOOD SECURITIES INC. | Buy | — |
| May 11, 2026 | CANACCORD GENUITY | Buy | — |
| Feb 23, 2026 | ALLIANCE GLOBAL PARTNERS | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 2, 2026
TORONTO, September 02, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session.
Benzinga · Aug 20, 2026
Sanity Group integration marks the next phase of Organigram’s global growth strategyFinn Age Hänsel appointed President, Rest of World & Chief Strategy OfficerAdrian Frenzel appointed Global Chief Operating
SeekingAlpha · Aug 12, 2026
2026-08-12. The following slide deck was published by Organigram Global Inc.
Yahoo · Aug 12, 2026
Moby summary of Organigram Global Inc.'s Q3 2026 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OGI.
